Skip to main content
SpringerLink
Log in
Book cover

Ventrikuläre Herzrhythmusstörungen pp 237–248Cite as

Kontrolle der medikamentösen Arrhythmiebehandlung (Mexiletin, Amiodarone) durch programmierte Ventrikelstimulation bei Patienten mit chronisch rezidivierenden Kammertachykardien

  • Conference paper

Zusammenfassung

Chronisch rezidivierende Kammertachykardien stellen potentiell lebensbedrohliche Herzrhythmusstörungen dar. Trotz großer Fortschritte auf dem Gebiet der Antiarrhythmika ist die empirisch gewählte konventionelle antiarrhythmische Therapie sehr häufig ineffektiv und für den Patienten mit langen Krankenhausaufenthalten sowie der Gefahr des plötzlichen Herztodes verbunden [1, 15, 35].

Mit Unterstützung der DFG (Ste 257/3, Lu 147/5)

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Armbrust CA, Levine SA (1950) Paroxysmal ventricular tachycardia: a study of one hundred and seven cases. Circulation 1:28

    PubMed  Google Scholar 

  2. Benditt DG, Pritchett ELC, Wallace AG, Gallagher JJ (1979) Recurrent ventricular tachycardia in man: evaluation of disopyramide therapy by intracardiac electrical stimulation. Eur J Cardiol 9:255

    PubMed  CAS  Google Scholar 

  3. Breithardt G, Seipel L, Abendroth RR, Loogen F (1980) Serial electrophysiological testing of antiarrhythmic drug efficacy in patients with recurrent ventricular tachycardia. Eur Heart J 1:11

    PubMed  CAS  Google Scholar 

  4. Campbell NPS, Kelly JG, Shanks RG, Chaturvedi NC, Strong JE, Pantridge JF (1973) Mexiletine (Kö 1173) in the management of ventricular dysrhythmias. Lancet 2:404

    Article  PubMed  CAS  Google Scholar 

  5. Charlier R (1970) Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptors. Br J Pharmacol 39:668

    PubMed  CAS  Google Scholar 

  6. Dreifus LS, Ogawa S (1977) Quality of the ideal antiarrhythmic drug. Am J Cardiol 39:466

    Article  PubMed  CAS  Google Scholar 

  7. Fisher JD, Cohen HL, Mehra R, Altschuler H, Escher DJW, Furman S (1977) Cardiac pacing and pacemakers. II. Serial electrophysiologic-pharmacologic testing for control of recurrent tachyarrhythmias. Am Heart J 93:658

    Article  PubMed  CAS  Google Scholar 

  8. Goupil N, Lenfant J (1976) The effects of amiodarone on the sinus node activity of the rabbit heart. Eur J Pharmacol 39:23

    Article  PubMed  CAS  Google Scholar 

  9. Han J, Millet D, Chizzonitti D, Moe GK (1966) Temporal dispersion of recovery of excitability in atrium and ventricle as a function of heart rate. Am Heart J 71:481

    Article  PubMed  CAS  Google Scholar 

  10. Hartzler GO, Maloney JD (1977) Programmed ventricular stimulation in management of recurrent ventricular tachycardia. Mayo Clin Proc 52:731

    PubMed  CAS  Google Scholar 

  11. Heger JJ, Nattel S, Rinkenberger RL, Zipes DP (1980) Mexiletine therapy in 15 patients with drug-resistant ventricular tachycardia. Am J Cardiol 45:627

    Article  PubMed  CAS  Google Scholar 

  12. Herling IM, Horowitz LN, Josephson ME (1980) Ventricular ectopic activity after medical and surgical treatment for recurrent sustained ventricular tachycardia. Am J Cardiol 45:633

    Article  PubMed  CAS  Google Scholar 

  13. Horowitz LN, Josephson ME, Farshidi A, Spielmann SR, Michelson EL, Greenspan AM (1978) Recurrent sustained ventricular tachycardia. 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens. Circulation 58:986

    PubMed  CAS  Google Scholar 

  14. Leak D, Eydt JN (1979) Control of refractory cardiac arrhythmias with amiodarone. Arch Intern Med 425

    Google Scholar 

  15. Lown B, Graboys TB (1977) Management of patients with malignant ventricular arrhythmias. Am J Cardiol 39:910

    Article  PubMed  CAS  Google Scholar 

  16. Manz M, Steinbeck G, Lüderitz B (1980) Mexiletin und Amiodarone bei rezidivierender Kammertachykardie — Untersuchung mit programmierter Ventrikelstimulation (Abstr). Z Kardiol 69:204

    Google Scholar 

  17. Mason JW, Winkle RA (1978) Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia. Circulation 58:971

    PubMed  CAS  Google Scholar 

  18. Pedersen DH, Zipes DP, Foster PR, Troup PJ (1979) Ventricular tachycardia and ventricular fibrillation in a young population. Circulation 60:988

    PubMed  CAS  Google Scholar 

  19. Podrid PJ, Schoeneberger A, Lown B (1980) Congestive heart failure caused by oral disopyramide. N Engl J Med 302:614

    Article  PubMed  CAS  Google Scholar 

  20. Polster P, Broekhuyen J (1976) The adrenergic antagonism of amiodarone. Biochem Pharmacol 25:131

    Article  PubMed  CAS  Google Scholar 

  21. Rosenbaum MB, Chiale PA, Halpern MS, Nau GJ, Przybylski J, Levi RJ, Lazzari JO, Elizari MV (1976) Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol 38:934

    Article  PubMed  CAS  Google Scholar 

  22. Seipel L, Breithardt G (1978) Electrophysiological effects of mexiletine in man: influence on stimulus-induced ventricular arrhythmias. In: Sandøe E, Julian DG, Bell JW (eds) Management of ventricular tachycardia — role of mexiletine. Excerpta Medica, Amsterdam Oxford, p 219

    Google Scholar 

  23. Singh BN, Vaughan Williams EM (1970) The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol 39:657

    PubMed  CAS  Google Scholar 

  24. Steinbeck G, Manz M, Lüderitz B (1980) Möglichkeiten und Risiken der programmierten Ventrikelstimulation bei rezidivierenden Kammertachykardien (Abstr). Z Kardiol 69:211

    Google Scholar 

  25. Steinbeck G, Manz M, Lüderitz B (1981) Elektrostimulation bei tachykarden Herzrhythmusstörungen — Pathophysiologie und klinische Anwendung. Dieses Buch S. 344

    Google Scholar 

  26. Talbot RG, Nimmo J, Julian DG, Clark RA, Neilson JMM, Prescott LF (1973) Treatment of ventricular arrhythmias with mexiletine (Kö 1173). Lancet 2:399

    Article  PubMed  CAS  Google Scholar 

  27. Talbot RG, Julian JG, Prescott LF (1976) Long-term treatment of ventricular arrhythmias with oral mexiletine. Am Heart J 91:58

    Article  PubMed  CAS  Google Scholar 

  28. Vastesaeger M, Gillot P, Rasson G (1967) Etude clinique d’une nouvelle médication antiangoreuse. Acta Cardiol (Brux) 22:483

    Google Scholar 

  29. Vismara LA, Vera Z, Miller RR, Mason DT (1977) Efficacy of disopyramide phosphate in the treatment of refractory ventricular tachycardia. Am J Cardiol 39:1027

    Article  PubMed  CAS  Google Scholar 

  30. Wellens HJJ, Schuilenburg RM, Durrer D (1972) Electrical stimulation of the heart in patients with ventricular tachycardia. Circulation 46:216

    PubMed  CAS  Google Scholar 

  31. Wellens HJJ, Düren DR, Liem KL, Lie KI (1975) Effect of digitalis in patients with paroxysmal atrioventricular nodal tachycardia. Circulation 52:779

    PubMed  CAS  Google Scholar 

  32. Wellens HJJ, Düren DR, Lie KI (1976) Observations on mechanisms of ventricular tachycardia in man. Circulation 54:237

    PubMed  CAS  Google Scholar 

  33. Wellens HJJ, Lie KI, Bär FW, Wesdorp JC, Dohmen HJ, Düren DR, Durrer D (1976) Effect of amiodarone in the Wolff-Parkinson-White-Syndrome. Am J Cardiol 38:189

    Article  PubMed  CAS  Google Scholar 

  34. Wellens HJJ, Bär FW, Lie KI, Düren DR, Dohmen HJ (1977) Effect of procainamide, propranolol and verapamil on mechanism of tachycardia in patients with chronic recurrent ventricular tachycardia. Am J Cardiol 40:579

    Article  PubMed  CAS  Google Scholar 

  35. Winkle RA, Alderman EL, Fitzgerald JW, Harrison DC (1976) Treatment of recurrent symptomatic ventricular tachycardia. Ann Intern Med 85:1

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik I der Universität, Klinikum Großhadern, Marchioninistraße 15, D-8000, München 70, Deutschland

    Priv. Doz. Dr. G. Steinbeck, Dr. M. Manz & Prof. Dr. B. Lüderitz

Authors
  1. Priv. Doz. Dr. G. Steinbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. M. Manz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prof. Dr. B. Lüderitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik I der Universität München, Klinikum Großhadern, Marchioninistraße 15, D-8000, München 70, Deutschland

    Berndt Lüderitz

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Steinbeck, G., Manz, M., Lüderitz, B. (1981). Kontrolle der medikamentösen Arrhythmiebehandlung (Mexiletin, Amiodarone) durch programmierte Ventrikelstimulation bei Patienten mit chronisch rezidivierenden Kammertachykardien. In: Lüderitz, B. (eds) Ventrikuläre Herzrhythmusstörungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67951-3_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-67951-3_22

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-67952-0

  • Online ISBN: 978-3-642-67951-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation